Reaction

Cardioversion reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,387 reports · 31 co-occurring drugs

As of the last recalculation, Cardioversion appears in 1,387 FAERS reports alongside 31 co-occurring drug terms. The strongest observed disproportionality signal is DOFETILIDE (PRR 81.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Dofetilide5581.882.2
Bosentan9229.329.3
Tafamidis2025.825.9
Sotalol Hydrochloride2825.825.8
Selexipag4325.725.8
Dronedarone1623.823.8
Epoprostenol1719.719.7
Ranolazine1318.918.9
Icosapent Ethyl1017.717.8
Rivaroxaban19316.016.0
Digoxin7215.815.8
Apixaban6615.515.5
Dabigatran Etexilate Mesylate6514.014.1
Macitentan6214.014.0
Amiodarone Hydrochloride1013.513.5
Dabigatran Etexilate6513.113.1
Warfarin Sodium3812.612.6
Sildenafil Powder,2812.012.0
Sildenafil4211.211.2
Riociguat2310.710.8
Warfarin8510.610.6
Sildenafil Citrate769.49.4
Fluticasone Propionate And Salmeterol248.88.8
Tadalafil446.86.8
Umeclidinium46.76.7
Dolutegravir Sodium46.76.7
Ambrisentan485.95.9
Bosutinib35.05.0
Agalsidase Beta34.94.9
Relugolix74.54.5
Emtricitabine And Tenofovir Alafenamide34.04.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.